A detailed history of Bank Ozk transactions in Zoetis Inc. stock. As of the latest transaction made, Bank Ozk holds 2,139 shares of ZTS stock, worth $387,843. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,139
Previous 6,350 66.31%
Holding current value
$387,843
Previous $1.07 Million 65.55%
% of portfolio
0.16%
Previous 0.49%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$145.54 - $178.83 $612,868 - $753,053
-4,211 Reduced 66.31%
2,139 $370,000
Q1 2024

May 10, 2024

BUY
$165.67 - $199.94 $89,793 - $108,367
542 Added 9.33%
6,350 $1.07 Million
Q4 2023

Feb 02, 2024

BUY
$151.44 - $200.09 $43,463 - $57,425
287 Added 5.2%
5,808 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $609,893 - $703,417
3,649 Added 194.93%
5,521 $960,000
Q2 2023

Jul 27, 2023

BUY
$160.94 - $186.23 $301,279 - $348,622
1,872 New
1,872 $322,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bank Ozk Portfolio

Follow Bank Ozk and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Ozk, based on Form 13F filings with the SEC.

News

Stay updated on Bank Ozk with notifications on news.